These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 2985096

  • 1. Differentiating aspects of opioid receptor binding by [3H](-) (1R,5R,9R,2''S)-5,9-dimethyl-2-tetrahydrofurfuryl-2'-hydroxy-6,7- benzomorphan hydrochloride ([3H]Mr 2034), a drug preferentially acting on kappa-receptors.
    Ensinger HA.
    Arzneimittelforschung; 1985; 35(1A):447-51. PubMed ID: 2985096
    [Abstract] [Full Text] [Related]

  • 2. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB, Schmidt WK, Kuhar MJ.
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [Abstract] [Full Text] [Related]

  • 3. [3H]Mr 2034 labels a high affinity opioid kappa-receptor not accessible to naloxazone.
    Ensinger HA.
    Eur J Pharmacol; 1983 Apr 22; 89(1-2):143-7. PubMed ID: 6305681
    [Abstract] [Full Text] [Related]

  • 4. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct 22; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 5. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ, Millan MJ, Herz A.
    J Pharmacol Exp Ther; 1988 Nov 22; 247(2):729-36. PubMed ID: 2846828
    [Abstract] [Full Text] [Related]

  • 6. The binding to rat brain homogenates of Mr2034, a universal opiate.
    Johnson N, Pasternak GW.
    Life Sci; 1983 Sep 05; 33(10):985-91. PubMed ID: 6310291
    [Abstract] [Full Text] [Related]

  • 7. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes.
    Tam SW, Liu-Chen LY.
    J Pharmacol Exp Ther; 1986 Nov 05; 239(2):351-7. PubMed ID: 3021954
    [Abstract] [Full Text] [Related]

  • 8. Solubilization and preliminary characterization of mu and kappa opiate receptor subtypes from rat brain.
    Chow T, Zukin RS.
    Mol Pharmacol; 1983 Sep 05; 24(2):203-12. PubMed ID: 6310362
    [Abstract] [Full Text] [Related]

  • 9. Benzomorphan sites are ligand recognition sites of putative epsilon-receptors.
    Chang KJ, Blanchard SG, Cuatrecasas P.
    Mol Pharmacol; 1984 Nov 05; 26(3):484-8. PubMed ID: 6149459
    [Abstract] [Full Text] [Related]

  • 10. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C.
    Werling LL, Zarr GD, Brown SR, Cox BM.
    J Pharmacol Exp Ther; 1985 Jun 05; 233(3):722-8. PubMed ID: 2989494
    [Abstract] [Full Text] [Related]

  • 11. Opioid receptors of bovine posterior pituitary neurosecretosomes are exclusively kappa.
    Pesce GO, Lang MA, Cruciani RA, Russell JT, Gainer H, Rodbard D.
    NIDA Res Monogr; 1986 Jun 05; 75():77-80. PubMed ID: 2893283
    [Abstract] [Full Text] [Related]

  • 12. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul 05; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 13. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes.
    Werling LL, Brown SR, Puttfarcken P, Cox BM.
    Mol Pharmacol; 1986 Aug 05; 30(2):90-5. PubMed ID: 3016504
    [Abstract] [Full Text] [Related]

  • 14. Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).
    Chang KJ, Hazum E, Cuatrecasas P.
    Proc Natl Acad Sci U S A; 1980 Aug 05; 77(8):4469-73. PubMed ID: 6254028
    [Abstract] [Full Text] [Related]

  • 15. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites.
    Nishimura SL, Recht LD, Pasternak GW.
    Mol Pharmacol; 1984 Jan 05; 25(1):29-37. PubMed ID: 6323950
    [Abstract] [Full Text] [Related]

  • 16. Relation of diltiazem binding sites to opioid receptor subtypes in the guinea-pig brain.
    Ishizuka Y, Oka T.
    Tokai J Exp Clin Med; 1987 Mar 05; 12(1):11-7. PubMed ID: 2835832
    [Abstract] [Full Text] [Related]

  • 17. Interaction of beta-funaltrexamine with [3H]cycloFOXY binding in rat brain: further evidence that beta-FNA alkylates the opioid receptor complex.
    Rothman RB, Bykov V, Mahboubi A, Long JB, Jiang Q, Porreca F, de Costa BR, Jacobson AE, Rice KC, Holaday JW.
    Synapse; 1991 Jun 05; 8(2):86-99. PubMed ID: 1652797
    [Abstract] [Full Text] [Related]

  • 18. Traumatic injury alters opiate receptor binding in rat spinal cord.
    Krumins SA, Faden AI.
    Ann Neurol; 1986 May 05; 19(5):498-501. PubMed ID: 3013077
    [Abstract] [Full Text] [Related]

  • 19. Modulation of rat brain opioid receptors by cannabinoids.
    Vaysse PJ, Gardner EL, Zukin RS.
    J Pharmacol Exp Ther; 1987 May 05; 241(2):534-9. PubMed ID: 3033219
    [Abstract] [Full Text] [Related]

  • 20. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y, Simon EJ.
    J Pharmacol Exp Ther; 1984 Aug 05; 230(2):383-6. PubMed ID: 6086884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.